Medical devices, healthcare technology and the business of care
510(k) clearance · K260783

Venus Diamond; Venus Diamond Flow; Venus Pearl; Venus Bulk Flow One

Kulzer, LLC · Decision date Mar 11, 2026

FDA DECISIONK260783

What did the FDA decide?

FDA records K260783 as a 510(k) premarket notification, with a decision dated Mar 11, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Mar 11, 2026

FDA source record

Regulatory record facts

Identifier
K260783
Regulatory pathway
510(k) premarket notification
Applicant
Kulzer, LLC
Product code
EBF
Decision code
SESE
Decision date
Mar 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Material, Tooth Shade, Resin.

Applicant
Kulzer, LLC
Product code
EBF
FDA device class
2

FDA decision timeline

  1. K260783 received

    Application receipt date recorded by FDA.

  2. K260783 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code EBF

Product / regulatory recordCompanyPathwayDecision dateSource
Spident Co., Ltd.510(k) clearanceSep 21, 2026FDA
GC America, Inc.510(k) clearanceSep 10, 2026FDA
Guilin Kevin Peter Technology Co., Ltd.510(k) clearanceAug 31, 2026FDA
Ivoclar Vivadent, Inc.510(k) clearanceJul 1, 2026FDA
Ultradent Products Inc.510(k) clearanceJul 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kulzer, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
South Bend, IN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records